resources

AstraZeneca SCISSOR Summary of Journal of Controlled Release article 2025

AstraZeneca SCISSOR Summary of Journal of Controlled Release article 2025

Video

Preview - This content has been restricted to logged in users only.

Watch a summary of AstraZeneca’s study using SCISSOR to predict subcutaneous bioavailability and explore IVIVC for monoclonal antibodies.
AstraZeneca SCISSOR Summary of Journal of Controlled Release article 2025

Video

Listen to Pion’s Development Scientist, Conor Gomes summarize arecent publication by AstraZeneca in the Journal of Controlled Release where they used SCISSOR to investigate in vitroin vivo correlations: ‘Predicting human subcutaneous bioavailability of monoclonal antibodies using an integrated in-vitro/in silico approach’

Previous post